Dynavax Technologies Corp (DVAX)

wontfindaname (< 20) Submitted: 3/18/2008 5:49:41 PM : Start Price: $2.46 DVAX Score: -29.04

Expect the huge gap to get filled over the next few days and a slow rise back to 6 over the next couple of months.

uberpaige (< 20) Submitted: 2/26/2007 2:12:23 PM : Start Price: $5.20 DVAX Score: -56.55

another hope for quick accuracy points.

foolphighter (< 20) Submitted: 1/12/2007 2:11:42 AM : Start Price: $6.02 DVAX Score: -61.59

Small biotech has recently released promising late stage trial results for its HEPLSAV hepatitus B vaccine drug, as well as encouraging earlier stage results for its TLR9 agonist in cancer indications. The stock took a large hit Jan. 8th when its TOLAMBA allergy drug failed to show therapeutic benefit based on interim analysis, that appears to present a buying opportunity, particularly since the reason for the failure appears to be the lack of clinically significant disease in the study population. Cash of $1.50/share & no debt and the recent filing of a $100M shelf registration suggests the company is well-positioned to leverage its recent progress into further positive developments. the stock appears to offer a reasonable risk/reward after the recent sell-off.

tekrider (< 20) Submitted: 12/27/2006 11:22:09 AM : Start Price: $8.98 DVAX Score: -68.39

this company has the best TLR-9 technology and excellent recent clinical trial results on both its allergy program and hepatitis B vaccine program, both of which address large markets.

southernair (< 20) Submitted: 12/19/2006 3:50:10 PM : Start Price: $9.00 DVAX Score: -68.89

This Co. has a cure for hayfever. There's a very large demand for such a product. Buckle up your seat belts for a nice ride up.

biodetector (31.78) Submitted: 12/15/2006 12:09:51 PM : Start Price: $9.37 DVAX Score: -68.87

I was evaluating their research data regarding influenza vaccines and missed the doubling in stock price, but this may just be the start. Their patented methods widen the range of protection from immunizations. This could be HUGE if it means protection from future viral epidemics.

billblattner (72.18) Submitted: 12/12/2006 10:49:57 AM : Start Price: $9.90 DVAX Score: -70.33

This sock is moving up, and its on news that has nothing to do with the alergy break thu, that will propel this company to the outer limits. All of my family has an alergy problem and are waiting for this pill or shot.

hawkider (57.69) Submitted: 12/7/2006 4:04:53 PM : Start Price: $9.52 DVAX Score: +70.13

House of cards

halmcneely (27.97) Submitted: 11/24/2006 5:17:17 PM : Start Price: $7.70 DVAX Score: -67.44

Stong findings for a much-needed vaccine; results exceed early prognosis. Large populations with Rag Weed Allergy get sustained releif.

moscabo (20.85) Submitted: 11/17/2006 11:06:39 AM : Start Price: $7.60 DVAX Score: -67.63

Bear Stearns upgraded to outperform 11/17

baronvonlong (< 20) Submitted: 10/23/2006 6:02:49 PM : Start Price: $6.20 DVAX Score: -65.15

alot of good things in their pipeline

bpub (42.62) Submitted: 10/16/2006 4:28:32 PM : Start Price: $7.10 DVAX Score: -68.40

Heavy insider trading.

bikdout (22.93) Submitted: 10/12/2006 1:45:38 PM : Start Price: $6.62 DVAX Score: -67.14

This small cap stock has just broken out with experimantal studies showing their new product does effectively relieve ragweed allergies.

Inv4Peter (38.54) Submitted: 10/11/2006 12:12:18 PM : Start Price: $6.86 DVAX Score: -68.83

New product hype will die down in a few weeks.

b5l8 (< 20) Submitted: 10/6/2006 5:37:50 PM : Start Price: $7.29 DVAX Score: -69.83

MY on3 D4y PrED1c+10n on +Hi5 5+OcK 1$ +7%;-)